Jove
Visualize
Contact Us

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Damage control surgery - massive pulmonary embolism complicated by sever bleeding from the liver.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2025
Same author

Incarceration of Bochdalek hernia in an adult - case report.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2024
Same author

[Vascular complications after endovascular interventions].

Deutsche medizinische Wochenschrift (1946)·2012
Same author

[On the current debate on lowering LDL cholesterol with ezetimibe].

Deutsche medizinische Wochenschrift (1946)·2010
Same author

[Cardiopulmonary exercise tests -- proposals for standardization and interpretation].

Pneumologie (Stuttgart, Germany)·2004
Same author

[Cardioprotection by acarbose--pro].

Deutsche medizinische Wochenschrift (1946)·2004
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 22, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

[Hypoglycemia - frequency, causes, induced costs].

H-W M Breuer1, P Ptak

  • 1Klinik für Innere Medizin, Knappschaftskrankenhaus Sulzbach/Saar. h.breuer@kksulzbach.de

Deutsche Medizinische Wochenschrift (1946)
|May 3, 2012
PubMed
Summary
This summary is machine-generated.

Hypoglycemia in elderly patients often requires hospitalization. Personalized diabetes treatment is crucial to prevent these episodes, reduce hospital stays, and lower associated healthcare costs.

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Related Experiment Videos

Last Updated: May 22, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Area of Science:

  • Endocrinology
  • Geriatrics
  • Pharmacology

Context:

  • Hypoglycemic episodes are significant complications of diabetes management, frequently leading to hospital admissions, particularly in elderly populations.
  • Inadequate diabetes treatment contributes to adverse events, necessitating a closer examination of contributing factors and patient management strategies.

Purpose:

  • To analyze the underlying causes and psychosocial factors of hypoglycemia in hospitalized patients.
  • To assess the demographic characteristics, medication associations, and healthcare costs related to hypoglycemia admissions.

Summary:

  • A study of 110 hospitalized patients (mean age 77.8 years, 99 with type 2 diabetes) revealed hypoglycemia was most commonly linked to insulin (67 episodes) and sulfonylureas (25 episodes).
  • Hospital stays averaged 10.4 days for hypoglycemia admissions, with associated costs around €3,158 for a subset of patients.
  • Impaired renal function was noted in a significant portion of patients, highlighting potential medication management challenges.

Impact:

  • Emphasizes the importance of patient-adapted diabetes treatment, especially for the elderly, to prevent hypoglycemia.
  • Highlights the potential for substantial cost savings and improved patient outcomes by preventing hypoglycemia-related hospitalizations and complications.